Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Université de Montréal
$120,000.00
Harnessing the potential of antibody-dependent cellular phagocytosis to eliminate HIV-1-infected cells
FY 2025-26
Summary
HIV-1 remains a global healthcare concern. Although antiretroviral therapy has greatly improved the outcomes of people with HIV-1 (PWH), current treatments are unable eliminate HIV-1-infected cells, which form the viral reservoir. Antibody-based therapeutic approaches targeting the HIV-1 envelope glycoprotein (Env) are particularly of interest, as they could potentially allow to identify and eliminate HIV-1-infected cells. In addition to their capacity to inhibit viral entry, antibodies can also mediate Fc-effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), which are both mechanisms that result in the elimination of infected cells. Our research group has previously shown that HIV-1-infected cells could be made vulnerable to elimination by ADCC mediated by antibodies naturally present in the plasma of PWH in vitro, as well as in a humanized mouse model. Moreover, ADCP has been associated with a level of protection against HIV-1 acquisition in vaccine trials, but its role in the elimination of HIV-1-infected cells is less described. The goal of my PhD is therefore to evaluate the ability of antibodies naturally present in PWH to mediate ADCP responses and to explore different strategies to improve the potential of this immune mechanism in the context of HIV-1. Better understanding the contribution of different Fc-effector functions like ADCP in the elimination of HIV-1-infected cells could help guide the development of new therapeutic approaches to help PWH.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559385
Name
Bélanger Étienne
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Harnessing the potential of antibody-dependent cellular phagocytosis to eliminate HIV-1-infected cells
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Antibodies; Antibody-Dependent Cellular Phagocytosis; Envelope Glycoprotein; Fc-Effector Functions; Flow Cytometry; Hiv-1; Primary Cells; Therapeutic Development
Abstract
HIV-1 remains a global healthcare concern. Although antiretroviral therapy has greatly improved the outcomes of people with HIV-1 (PWH), current treatments are unable eliminate HIV-1-infected cells, which form the viral reservoir. Antibody-based therapeutic approaches targeting the HIV-1 envelope glycoprotein (Env) are particularly of interest, as they could potentially allow to identify and eliminate HIV-1-infected cells. In addition to their capacity to inhibit viral entry, antibodies can also mediate Fc-effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), which are both mechanisms that result in the elimination of infected cells. Our research group has previously shown that HIV-1-infected cells could be made vulnerable to elimination by ADCC mediated by antibodies naturally present in the plasma of PWH in vitro, as well as in a humanized mouse model. Moreover, ADCP has been associated with a level of protection against HIV-1 acquisition in vaccine trials, but its role in the elimination of HIV-1-infected cells is less described. The goal of my PhD is therefore to evaluate the ability of antibodies naturally present in PWH to mediate ADCP responses and to explore different strategies to improve the potential of this immune mechanism in the context of HIV-1. Better understanding the contribution of different Fc-effector functions like ADCP in the elimination of HIV-1-infected cells could help guide the development of new therapeutic approaches to help PWH.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bélanger, Étienne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~